Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio™ to treat serious neurologically mediated conditions, announced the appointment of Lisa Delfini, CPA, as Chief Financial Officer and Danine Summers, as Vice President, Medical Affairs.
August 9, 2021
· 6 min read